ANNEXON, INC. Cash and Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect
ANNEXON, INC. (ANNX) reported Cash and Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect of $224.63 million for the 12-month period ending 2020-12-31, per its 10-K filed 2021-03-25.
Discontinued › Cash Flow › Change in Cash
us-gaap:CashAndCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect · last filed 2021-03-25
- ANNEXON, INC. cash and cash equivalents, period increase (decrease), excluding exchange rate effect for fiscal 2020 was $224.63M.
- ANNEXON, INC. cash and cash equivalents, period increase (decrease), excluding exchange rate effect for fiscal 2019 was -$230.00K.
| Period end | Cash and Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect 6 month | Cash and Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect 9 month | Cash and Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect 12 month |
|---|---|---|---|
| 2020-12-31 | $224.63M 10-K · filed 2021-03-25 | ||
| 2020-09-30 | $326.75M 10-Q · filed 2020-11-16 | ||
| 2020-06-30 | $80.83M 10-Q · filed 2020-09-08 | ||
| 2019-12-31 | -$230.00K 10-K · filed 2021-03-25 | ||
| 2019-09-30 | $9.50M 10-Q · filed 2020-11-16 | ||
| 2019-06-30 | -$12.71M 10-Q · filed 2020-09-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |
| SPRUCE BIOSCIENCES, INC. (SPRB) | United States | $0.142B | -2.89 |
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B | |
| Curanex Pharmaceuticals Inc (CURX) | United States | $0.138B | |
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| LIFECORE BIOMEDICAL, INC. DE (LFCR) | United States | $0.163B | -8.50 |